Connect with us

Health

Novel Approach for Intravenous Cancer Immunotherapy – Genetic Engineering & Biotechnology News

Researchers report they have developed nanoparticles to deliver STING agonists and metal ions for intravenous cancer immunotherapy….

Published

on

Article feature image

Researchers at the University of Michigan (U-M) School of Pharmacy and the Rogel Cancer Center took a different approach to boosting the STING pathway. The team observed that adding the nutritional metal ion manganese to STING agonists boosted STING’s tumor-fighting…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending